Država: Velika Britanija
Jezik: angleščina
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nicorandil
DE Pharmaceuticals
C01DX16
Nicorandil
20mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060300
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Nicorandil Tablets are and what they are used for 2. What you need to know before you take Nicorandil Tablets 3. How to take Nicorandil Tablets 4. Possible side effects 5. How to store Nicorandil Tablets 6. Contents of the pack and other information 1. WHAT NICORANDIL TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Nicorandil 10mg Tablets or Nicorandil 20mg Tablets (referred to as Nicorandil Tablets throughout this leaflet). Nicorandil Tablets contain the active substance “nicorandil”. This belongs to a group of medicines called 'potassium-channel activators'. Nicorandil Tablets are used to prevent or reduce painful signs (“angina pectoris”) of your heart disease. It is used in adults who cannot take heart medicines called “beta-blockers” or “calcium antagonists”. Nicorandil Tablets work by increasing the blood flow through the blood vessels of the heart. They improve the blood and oxygen supply of your heart muscle and reduces its workload. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NICORANDIL TABLETS DO NOT TAKE NICORANDIL TABLETS IF: • You are allergic (hypersensitive) to nicorandil or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue. • You have severe low blood pressure (“hypotension”). Signs include feeling dizzy, light- headed or faint. • You hav Preberite celoten dokument
OBJECT 1 NICORANDIL 20MG TABLETS Summary of Product Characteristics Updated 29-Jul-2018 | Dexcel Pharma Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Nicorandil 20mg Tablets 2. Qualitative and quantitative composition Nicorandil 20mg Each tablet contains 20mg nicorandil. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet, white to off white, round, scored on one side and engraved with "20" on the other side. The tablet can be divided into equal halves. 4. Clinical particulars 4.1 Therapeutic indications Nicorandil 20mg Tablets are indicated in adults for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or have a contraindication or intolerance to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists). 4.2 Posology and method of administration POSOLOGY The usual therapeutic range is 10 to 20 mg twice daily. The usual starting dose is 10 mg twice daily (bid), in t Preberite celoten dokument